The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
The Effect of Standardizing Procedures for Subcutaneous Injections of Low-molecular-weight Heparin on Patients With Cardiovascular Diseases: A Cluster Randomized Controlled Trial
The Hong Kong Polytechnic University
180 participants
Jun 24, 2025
INTERVENTIONAL
Conditions
Summary
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Eligibility
Inclusion Criteria2
- patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
- Chinese
Exclusion Criteria3
- cognitively impaired
- unconscious
- refuse to participate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses.
Nurses administer LMWH according to the standardized evidence-based protocol.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06776159